GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Yan Tat Group Holdings Ltd (HKSE:01480) » Definitions » Valuation Rank

Yan Tat Group Holdings (HKSE:01480) Valuation Rank


View and export this data going back to 2014. Start your Free Trial

What is Yan Tat Group Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Yan Tat Group Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Yan Tat Group Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Yan Tat Group Holdings (HKSE:01480) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Yantat Road (West Gate), 81 Lijing South Road (East Main Gate), Pingshan New District, Shenzhen, CHN
Yan Tat Group Holdings Ltd is engaged in the manufacture and sale of printed circuit boards (PCB). The company's conventional and special material PCBs comprise three product categories, Single-sided, Double-sided, and Multi-layered. Its products are principally used in sectors such as communication, automobile, industrial automation, consumer electronics, and medicine. In addition, it is also involved in the property holding business. The company has a business presence in Mainland China, Europe, Hong Kong, North America, Asia, Africa, Oceania, and South America, of which key revenue is generated from Mainland China.